P38 MAPK-IN-7
P38 MAPK-IN-7 (Compound 2) is an orally active, potent and selective p38 MAP kinase inhibitor (IC50=170 nM) . p38 MAPK-IN-7 is promising for research of inflammatory diseases such as rheumatoid arthritis and septic shock[1].
Product Specifications
CAS Number
165806-50-8
UNSPSC
12352005
Target
P38 MAPK
Related Pathways
MAPK/ERK Pathway
Field of Research
Inflammation/Immunology
Smiles
FC1=CC=C(C2=C(C3=CC=NC(N)=N3)N(C(C)C)C=N2)C=C1
Molecular Formula
C16H16FN5
Molecular Weight
297.33
References & Citations
[1]Adams JL, et al. Pyrimidinylimidazole inhibitors of p38: cyclic N-1 imidazole substituents enhance p38 kinase inhibition and oral activity. Bioorg Med Chem Lett. 2001 Nov 5;11 (21) :2867-70.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
NBP2-81103-0.025mg 0.025 mg
Rabbit Monoclonal EDAR Antibody (EDAR12)
Sign In for Pricing
View Details 
MBS434041-01 0.05 mg
HIV-1 gp120 (AC10.0) (Clade B) protein (amino acid 36-514)
Sign In for Pricing
View Details MBS434041-02 5x 0.05 mg
HIV-1 gp120 (AC10.0) (Clade B) protein (amino acid 36-514)
Sign In for Pricing
View Details LC406431 20 µg
C3orf23 (TCAIM) (NM_173826) Human Over-expression Lysate
Sign In for Pricing
View Details